The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pregnancy-associated breast cancer: Tumor infiltrating lymphocytes TILting the balance?
 
Carsten Bakhuis
Research Funding - Gilead Sciences
 
Natalie ter Hoeve
No Relationships to Disclose
 
Sabine Linn
Consulting or Advisory Role - AstraZeneca/Merck (Inst); Daiichi Sankyo (Inst)
Research Funding - Agendia (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eurocept Pharmaceuticals (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - PCT/EP2022/073958 Method for assessing homologous recombination deficiency in ovarian cancer cells (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH (Inst)
 
Stefan Prekovic
No Relationships to Disclose
 
Elsken Van Der Wall
No Relationships to Disclose
 
Paul van Diest
Consulting or Advisory Role - PAIGE.AI; Sectra; Visiopharm
Patents, Royalties, Other Intellectual Property - DDX3 as a biomarker for cancer and methods related thereto (Inst)
 
Carmen van Dooijeweert
Honoraria - Benecke; Congress Care
Research Funding - Ellogon.AI (Inst); Gilead Sciences; PAIGE (Inst); Visiopharm (Inst)